CDK6 and sarcoma: In addition to BLCA, high transcriptional CDK6 mRNA also predicts poor prognosis in pancreatic adenocarcinoma, adrenocortical adenocarcinoma, uterine corpus endometrial carcinoma, lung adenocarcinoma, low-grade glioma, mesothelioma, and sarcoma from TCGA database analyzed using the UALCAN website (18).